Novo Nordisk stock share price today fell after the company announced that semaglutide, used in Ozempic and Wegovy, failed to slow Alzheimer’s progression in trials. Shares hit a four-year low, …
Novo Nordisk Stock Share Price Today: Why company’s shares are down? Here’s Alzheimer drug’s trial outcome, stock market impact, analysts insights
view original post